Keurig Dr Pepper, Inc (NASDAQ:KDP - Get Free Report) insider Mary Beth Denooyer sold 12,000 shares of Keurig Dr Pepper stock in a transaction on Tuesday, July 1st. The shares were sold at an average price of $33.64, for a total value of $403,680.00. Following the completion of the sale, the insider directly owned 94,511 shares of the company's stock, valued at $3,179,350.04. The trade was a 11.27% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.
Mary Beth Denooyer also recently made the following trade(s):
- On Friday, June 20th, Mary Beth Denooyer sold 12,000 shares of Keurig Dr Pepper stock. The shares were sold at an average price of $33.64, for a total transaction of $403,680.00.
- On Tuesday, June 3rd, Mary Beth Denooyer sold 12,000 shares of Keurig Dr Pepper stock. The stock was sold at an average price of $32.92, for a total value of $395,040.00.
- On Tuesday, May 6th, Mary Beth Denooyer sold 12,000 shares of Keurig Dr Pepper stock. The stock was sold at an average price of $34.11, for a total value of $409,320.00.
- On Thursday, April 17th, Mary Beth Denooyer sold 12,000 shares of Keurig Dr Pepper stock. The stock was sold at an average price of $35.59, for a total transaction of $427,080.00.
Keurig Dr Pepper Price Performance
Shares of NASDAQ:KDP traded down $0.41 during midday trading on Friday, hitting $33.44. 5,376,466 shares of the stock were exchanged, compared to its average volume of 10,907,306. The company has a current ratio of 0.47, a quick ratio of 0.31 and a debt-to-equity ratio of 0.49. The stock has a market cap of $45.41 billion, a P/E ratio of 30.40, a PEG ratio of 2.61 and a beta of 0.47. The company has a 50 day moving average price of $33.40 and a 200-day moving average price of $33.10. Keurig Dr Pepper, Inc has a twelve month low of $30.12 and a twelve month high of $38.28.
Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last issued its quarterly earnings data on Thursday, April 24th. The company reported $0.42 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.04. The firm had revenue of $3.64 billion during the quarter, compared to the consensus estimate of $3.57 billion. Keurig Dr Pepper had a return on equity of 10.86% and a net margin of 9.69%. The company's quarterly revenue was up 4.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.38 EPS. On average, research analysts forecast that Keurig Dr Pepper, Inc will post 1.92 earnings per share for the current year.
Keurig Dr Pepper Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 11th. Investors of record on Friday, June 27th will be paid a dividend of $0.23 per share. This represents a $0.92 annualized dividend and a dividend yield of 2.75%. The ex-dividend date of this dividend is Friday, June 27th. Keurig Dr Pepper's payout ratio is 83.64%.
Institutional Inflows and Outflows
Several institutional investors have recently bought and sold shares of KDP. Skandinaviska Enskilda Banken AB publ lifted its position in Keurig Dr Pepper by 53.1% during the fourth quarter. Skandinaviska Enskilda Banken AB publ now owns 325,398 shares of the company's stock worth $10,400,000 after buying an additional 112,819 shares during the period. Praxis Investment Management Inc. lifted its holdings in shares of Keurig Dr Pepper by 112.2% during the 1st quarter. Praxis Investment Management Inc. now owns 19,630 shares of the company's stock worth $672,000 after acquiring an additional 10,380 shares during the period. Oppenheimer & Co. Inc. purchased a new position in shares of Keurig Dr Pepper during the 4th quarter worth about $400,000. Aspire Private Capital LLC acquired a new position in Keurig Dr Pepper in the first quarter valued at $1,177,000. Finally, Vaughan Nelson Investment Management L.P. acquired a new stake in Keurig Dr Pepper during the 1st quarter worth approximately $4,091,000. 93.99% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
A number of research firms have weighed in on KDP. Piper Sandler raised Keurig Dr Pepper from a "neutral" rating to an "overweight" rating and increased their price objective for the stock from $35.00 to $40.00 in a research report on Wednesday, April 9th. HSBC raised shares of Keurig Dr Pepper from a "hold" rating to a "buy" rating and boosted their price objective for the company from $36.00 to $42.00 in a research note on Friday, April 25th. Hsbc Global Res upgraded shares of Keurig Dr Pepper from a "hold" rating to a "strong-buy" rating in a research note on Friday, April 25th. Morgan Stanley upgraded shares of Keurig Dr Pepper from an "equal weight" rating to an "overweight" rating and boosted their price target for the stock from $38.00 to $40.00 in a research note on Tuesday, April 1st. Finally, Argus began coverage on shares of Keurig Dr Pepper in a report on Wednesday, April 16th. They set a "buy" rating and a $40.00 price target for the company. Two investment analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, Keurig Dr Pepper currently has an average rating of "Moderate Buy" and an average target price of $39.92.
Get Our Latest Research Report on KDP
Keurig Dr Pepper Company Profile
(
Get Free Report)
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
Read More

Before you consider Keurig Dr Pepper, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.
While Keurig Dr Pepper currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.